BACKGROUND: Women with dense mammographic breast density (BD) have a 2-fold increased risk of developing primary breast cancer (BC). The authors hypothesized that dense mammographic BD also is associated with an increased risk of developing contralateral breast cancer (CBC). METHODS: Among female patients treated at The University of Texas MD Anderson Cancer Center for sporadic, AJCC stage I to stage III BC between January 1997 and December 2012, the authors identified patients who had developed metachronous CBC (cases) and selected 1:2 matched controls who did not develop CBC using incidence density sampling, matched on attainted age, year of diagnosis, and hormone receptor status of the first BC. Mammographic BD, assessed at the time of first BC diagnosis, was categorized as "nondense" (American College of Radiology breast categories of fatty or scattered density) or "dense" (American College of Radiology categories of heterogeneously dense or extremely dense). Multivariable conditional logistic regression models were used for statistical analysis. RESULTS: A total of 229 cases and 451 controls were evaluated. Among the cases, approximately 39.3% had nondense breast tissue and 60.7% had dense breast tissue. Among controls, approximately 48.3% had nondense breast tissue and 51.7% had dense breast tissue. After adjustment for potential prognostic risk factors for BC, the odds of developing CBC were found to be significantly higher for patients with dense breasts (odds ratio, 1.80; 95% confidence interval, 1.22-2.64 [P<.01]) than for those with nondense breasts. Patients who received chemotherapy or endocrine therapy were less likely to develop CBC. CONCLUSIONS: In women with primary BC, mammographic BD appears to be a risk factor for the development of CBC.
INTRODUCTION
It is established that women with dense mammographic breast density (BD) have a 2-fold increased risk of developing breast cancer (BC).
1,2 BD is essentially the ratio of fibroglandular tissue to fat. Three metrics that reflect the tissue composition of the breast commonly are used to characterize mammographic BD: 1) nondense area, which is breast fat tissue; 2) dense area, which is fibroglandular and stromal tissue; and 3) percentage density, which is the amount of dense tissue relative to the total breast area. 3 Several factors are known to be associated with dense BD; among these are young age and premenopausal status, as well as the use of postmenopausal estrogen replacement. [4] [5] [6] [7] [8] [9] In addition, it is hypothesized that there may be a genetic predisposition toward increased BD; however, to the best of our knowledge, the specific genetic factors remain unknown. 10, 11 Survivors of BC have an increased risk of developing contralateral breast cancer (CBC) compared with the risk of developing primary BC in the general female population. 12 Hence, it is important to identify the risk factors for developing CBC. Some of the known risk factors include young age at the time of diagnosis of primary BC, a family history of BC, estrogen receptor-positive primary tumor, and BRCA mutation. However, to our knowledge, it remains unknown whether dense BD is a risk factor for developing CBC. We hypothesized that patients with dense mammographic BD at the time of first diagnosis of BC would have an increased risk of developing metachronous CBC.
MATERIALS AND METHODS

Study Design and Patients
We performed a retrospective, nested case-control (1:2 matched) study of female patients with sporadic, AJCC stage I to stage III BC who were diagnosed between January 1997 and December 2012 and treated at The University of Texas MD Anderson Cancer Center (MDACC). Patients who had an additional diagnosis of metachronous CBC, defined as BC in the opposite breast diagnosed >6 months after detection of the first cancer, 13 were defined as cases, and patients who did not have CBC were defined as controls. The purpose of the study was to evaluate the evidence of a relationship between the mammographic BD of the original BC and the development of metachronous CBC, which was the primary endpoint of the current study. Using the estimated prevalence of dense breast 14 in the control population and the number of eligible cases in the current study sample, a 1:2 matched study appeared to have sufficient power to detect an odds ratio (OR) of 1.6 and to be feasible of control selection.
An incidence density sampling program developed by Richardson 15 was used for the selection of cases and their matched controls. 16 To serve as a control, a patient had to survive at least as long as the index case's age at the time of diagnosis of the CBC and have no CBC as an event. Because disease rates usually are strongly associated with age, we used attained age of the index case at the time of diagnosis of CBC as time scale for our matched controls. Matching on attained age removes the potential confounding effect of age on the development of CBC when matched analysis is performed. 15, 17, 18 In addition, we matched the controls on 2 additional covariates: the year of diagnosis and hormone receptor status of the primary BC, which are known risk factors. We chose 1 control for 3 cases and did not find a control for 1 case. Women who had received treatment before their initial visit to MDACC, those who had undergone a bilateral mastectomy, those who were BRCA-positive, and those with unknown tumor characteristics were excluded from the current analysis.
Study data were collected from the BC management system database of the breast medical oncology department at MDACC. Information was abstracted from patient charts and coded to protect patient privacy. The study was performed with approval from the MDACC Institutional Review Board (PA14-0877).
Mammographic BD Assessment
Mammographic BD was assessed using images obtained at the time of the first BC diagnosis. A retrospective chart review of the images was performed to record the BD. Radiologists determined mammographic BD qualitatively using visual assessment. The American College of Radiology classifies mammographic BD as: a) almost entirely fat (Breast Imaging Reporting and Data System [BI-RADS] 1 density); b) scattered areas of fibroglandular density (BI-RADS 2 density); c) heterogeneously dense (BI-RADS 3 density); or d) extremely dense (BI-RADS 4 density). 19 For the purposes of the current study, we categorized "a" and "b" density as "nondense" and "c" and "d" density as "dense." The recent classification was adapted as a conversion from the prior system to avoid confusing density categories with final assessment categories.
Statistical Analysis
Univariate conditional logistic regression models were used to examine the crude association between mammographic BD and metachronous CBC and other confounders, and multivariable conditional logistic regression models were used to examine the adjusted association between mammographic BD and metachronous CBC after adjusting for patient and disease characteristics, in which the maximum likelihood estimates were obtained using conditional likelihood for each matched group. 20 Likelihood ratio tests were used to evaluate the association between main exposure (ie, dense breast tissue), potential confounders, and outcome of interest (ie, metachronous CBC). A P value of .25 was used to select potential confounding risk factors for the multivariable analysis. 20, 21 Backward selection criteria were used to retain variables in the multivariable model using a significance level of .05. We also assessed the importance of the potential confounding variables on the basis of a 10% change in the estimate of association between dense breast tissue and development of CBC. 20 Statistical analyses were performed using SAS statistical software (version 9.4; SAS Institute Inc, Cary, NC) and STATA statistical software (version 12; StataCorp LP, College Station, Tex). 22 
RESULTS
Patient Characteristics
Of the 680 selected patients, 229 were cases and 451 were controls. Among the cases, 39.3% were classified as having nondense breast tissue and 60.7% were classified as having dense breast tissue. Among the controls, 48.3% had nondense breast tissue and 51.7% had dense breast tissue. Table 1 presents the characteristics of the cases and controls. Cases were more likely to have dense breast tissue compared with controls. In addition, the mean age at Original Article the time of diagnosis was 56 years in cases and controls at the time of BC diagnosis. There was a similar distribution of racial groups across cases and controls, and there was no significant difference noted with regard to family history characteristics.
The majority of cases and controls had stage I or II disease. Controls were slightly more likely to have invasive ductal disease compared with cases. Cases were less likely to have received chemotherapy or endocrine therapy. In terms of locoregional therapy, cases were more likely to have undergone a mastectomy and, correspondingly, were less likely to have received radiotherapy.
Univariate and Multivariable Analyses
In the univariate analysis ( and receipt of endocrine therapy (P<.01) were found to be associated with a decreased risk of developing metachronous CBC. Variables that were not found to be statistically significant in the univariate analysis but met the selection criteria as candidates in the multivariable models (ie, P<.25) were body mass index (BMI), race/ethnicity, and stage of disease. Neither family history nor tumor grade demonstrated marginal significance in the univariate analysis nor met the selection criteria for entering into the multivariable model. Variables evaluated in the multivariable analysis but then removed from the final model, either due to lack of statistical significance or because the removal of such variables did not change the association between mammographic BD and the development of metachronous CBC by at least 10%, were race/ethnicity, tumor stage, and grade. In the multivariable analysis ( 
Hormone Receptor Characteristics of the CBC
Given the association noted between mammographic BD and metachronous CBC, as well as previous literature suggesting that hormone therapy influences BD, 7 we examined the relationship between hormone receptor characteristics of the CBC event and mammographic BD at the time of first BC diagnosis to explore further potential sources of heterogeneity. We evaluated the percentage of hormone receptor-positive and hormone receptornegative CBCs as a function of mammographic BD. As shown in Figure 1 , the hormone receptor status of the CBCs did not differ between the dense and nondense breast tissue groups. DISCUSSION BD reflects as an independent increased risk factor for breast cancer. Although weight, BMI, age, menopausal status, nulliparity, family history, hormone use, and previous breast biopsy may all influence BD, BD is identified consistently as an independent risk factor after adjustment for other variables associated with both density and breast cancer risk. 23 Although this is well established, to our knowledge the relationship between BD and CBC is less clear. The purpose of the current study was to determine whether increased BD at the time of diagnosis of primary BC was associated with the development of metachronous CBC. In our retrospective case-control study, we found that patients who had dense breast tissue had a significantly increased risk of developing CBC (OR, 1.80; 95% CI, 1.22-2.64 [P<.01]). Because the effect of BD on cancer risk persists for at least 5 to 10 years after assessment, [23] [24] [25] BD at the time of the primary BC appears to be important. A similar study conducted by another group that presented 7684 women with BC who were followed by the Breast Cancer Surveillance Consortium demonstrated increased mammographic density to be a significant risk factor for CBC. Compared with the "almost entirely fat" category, the ORs for the "scattered density," "heterogeneously dense," and "extremely dense" categories of BD were, respectively, 1.55 (P5.068), 1.78 (P5 .015), and 2.14 (P5 .004). 26 In contrast to the current study findings, those from a previous study have suggested that mammographic BD at baseline did not appear to influence the risk of CBC in patients with BC. 27 This unexpected finding could be limited mainly by the small size of the study. The authors themselves gave an alternative explanation for the lack of an association between mammographic BD and the risk of CBC, which was that it could be there was a systematic difference in the mammographic BD of the patients with unilateral BC who were selected as controls for the study compared with patients with unilateral BC in general.
The current study cohort was matched on attainted age and hormone receptor status, which is an established risk factor for BC; women with hormone receptor-negative BC have been shown to have a 60% higher risk of developing CBC compared with those with hormone receptor-positive BC (OR, 1.6; 95% CI, 1.2-2.3). 28 We also observed an increased risk of developing metachronous CBC in women with a high BMI, as well as among women with invasive ductal disease. It has been proposed that patients who are overweight or obese at the time of their initial diagnosis of BC have a 50% increased risk of developing CBC after 10 years of follow-up. 29 With regard to the histologic subtype, several studies have shown that patients with lobular carcinoma, compared with other subtypes, have an increased risk of developing CBC. 30 In the current study cohort, we categorized other subtypes inclusive of lobular carcinoma that did demonstrate some significance for the development of CBC; this could be because lobular carcinomas are less easily visualized mammographically. 31 It is interesting to note that patients in the current study cohort who received chemotherapy (anthracyclinetaxane regimen) or endocrine therapy had a reduced risk of developing CBC. This is consistent with previous studies, which have shown a 35% to 40% reduction in the risk of developing CBC in women who were first treated with chemotherapy or endocrine therapy compared with those who did not receive any treatment. 32 A strength of the current study was the inclusion of many 10-year, 15-year, and 20-year survivors with highly annotated clinicopathologic data, as well as the availability of detailed patient and initial treatment information inclusive of patients treated at MDACC because the institute is a referral center. Reported rates of CBC are likely to vary because of dissimilar patient populations, lengths of follow-up, and variations in the definition of CBC. The nested case-control design of the current study allowed us to avoid some of these pitfalls. The current study is limited mainly by its retrospective nature and its small size, resulting from the large number of cases that were excluded because they did not meet the established study inclusion criteria. These exclusions could have introduced additional biases. In addition, the associations of the confounding variables in our multivariable analysis should be interpreted with caution because we used them as adjusting factors rather than as variables of primary interest.
Conclusions
Patients with dense breast tissue according to mammography appear to be more likely to develop metachronous CBC compared with patients with nondense breast tissue.
The hormone receptor status of the CBC was found to be independent of BD. Mammographic BD may be considered a risk factor for CBC in prognostic models to change the management of clinical practice to be able to adopt specific recommendations using more enhanced surveillance with imaging techniques such as magnetic resonance imaging for the detection of occult cancers among patients with dense tissue.
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